- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global In Vitro Lung Model Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Human lungs are delicate organs and are the main entrance for entry and exit of aerosolised materials and gases. In vitro lung model can be established by culturing macrophages, epithelial cells, and dendritic cells favourable for culture medium. Global in vitro lung model market was valued at approximately $180 Million in 2017 and is expected to generate revenue of around $431 Million by the end of 2024, growing at a CAGR of around 17.6% between 2017 and 2024. Rising focus on developing alternatives for animal testing models and a significant increase in research funding and venture capital investments are the factors enhancing the growth of the market. Lack of skilled professionals and unfavourable payment models are the factors which hamper the market growth. Growing number of drug discovery activities and applications in regenerative medicine, tissue engineering, and oncology research are the opportunities for the in vitro lung model market.
Research Study Objectives:
- Define, estimate, and forecast the In Vitro Lung Model market statistics by type, application, and regions concerning the individual growth drivers, market trends and their contribution toward the In Vitro Lung Model market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the In Vitro Lung Model Market Analysis
- Analysis and conclusions on the future In Vitro Lung Model market outlook.
Top-down and bottom-up approaches are used to validate the In Vitro Lung Model Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The In Vitro Lung Model Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the In Vitro Lung Model market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The In Vitro Lung Model market segmentation is as follows:
BY TYPE
- 2D Cell Models
- 3D Cell Models
By Application
- Applications of 2D Models
- Applications of 3D Models
Geographical Analysis:
In Vitro Lung Model Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the In Vitro Lung Model Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global In Vitro Lung Model Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant In Vitro Lung Model market players, such as
- American Type Culture Collection.
- Emulate, Inc.
- Lonza Group.
- MatTek Corporation.
- Epithelix SAS.
- Along with these companies, many other companies are considered in the report while analysing the Global In Vitro Lung Model competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements and the development of new 3D in vitro models
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Significant rise in research funding and venture capital investments
4.1.4. Growing incidence of preventable chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals
4.2.2. Unfavourable payment models
4.3. Market Opportunities
4.3.1. Applications in regenerative medicine, tissue engineering, and oncology research
4.3.2. Growing number of drug discovery activities
CHAPTER 5. GLOBAL IN VITRO LUNG MODEL MARKET – BY TYPE
5.1 Introduction
5.2 2D Cell Models
5.3 3D Cell Models
5.3.1Commercial 3D cell models
5.3.2In house 3D cell models
CHAPTER 6. GLOBAL IN VITRO LUNG MODEL MARKET – BY APPLICATION
6.1 Introduction
6.2 Applications of 2D Models
6.3 Applications of 3D Models
CHAPTER 7. GLOBAL IN VITRO LUNG MODEL MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL IN VITRO LUNG MODEL MARKET – COMPANY
PROFILES
8.1. Epithelix SAS.
8.2. MatTek Corporation
8.3. Lonza Group.
8.4. MIMETAS.
8.5. InSphero AG.
8.6. Emulate, Inc.
8.7. CN Bio Innovations.
8.8. Oncotheis.
8.9. TissUse GmbH.
8.10. American Type Culture Collection.
8.11. AlveoliX AG.
8.12. Well Doc Inc.
8.13. Twine Health, Inc.
8.14. Proteus Digital Health.
8.15. Zest Health, LLC.
CHAPTER 9. GLOBAL IN VITRO LUNG MODEL MARKET – COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,504.64 - €7,513.91
- INR: ₹222,637.29 - ₹667,911.87
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,148.85 - £6,446.56
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Human lungs are delicate organs and are the main entrance for entry and exit of aerosolised materials and gases. In vitro lung model can be established by culturing macrophages, epithelial cells, and dendritic cells favourable for culture medium. Global in vitro lung model market was valued at approximately $180 Million in 2017 and is expected to generate revenue of around $431 Million by the end of 2024, growing at a CAGR of around 17.6% between 2017 and 2024. Rising focus on developing alternatives for animal testing models and a significant increase in research funding and venture capital investments are the factors enhancing the growth of the market. Lack of skilled professionals and unfavourable payment models are the factors which hamper the market growth. Growing number of drug discovery activities and applications in regenerative medicine, tissue engineering, and oncology research are the opportunities for the in vitro lung model market.
Research Study Objectives:
- Define, estimate, and forecast the In Vitro Lung Model market statistics by type, application, and regions concerning the individual growth drivers, market trends and their contribution toward the In Vitro Lung Model market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the In Vitro Lung Model Market Analysis
- Analysis and conclusions on the future In Vitro Lung Model market outlook.
Top-down and bottom-up approaches are used to validate the In Vitro Lung Model Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The In Vitro Lung Model Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the In Vitro Lung Model market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The In Vitro Lung Model market segmentation is as follows:
BY TYPE
- 2D Cell Models
- 3D Cell Models
By Application
- Applications of 2D Models
- Applications of 3D Models
Geographical Analysis:
In Vitro Lung Model Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the In Vitro Lung Model Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global In Vitro Lung Model Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant In Vitro Lung Model market players, such as
- American Type Culture Collection.
- Emulate, Inc.
- Lonza Group.
- MatTek Corporation.
- Epithelix SAS.
- Along with these companies, many other companies are considered in the report while analysing the Global In Vitro Lung Model competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements and the development of new 3D in vitro models
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Significant rise in research funding and venture capital investments
4.1.4. Growing incidence of preventable chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals
4.2.2. Unfavourable payment models
4.3. Market Opportunities
4.3.1. Applications in regenerative medicine, tissue engineering, and oncology research
4.3.2. Growing number of drug discovery activities
CHAPTER 5. GLOBAL IN VITRO LUNG MODEL MARKET – BY TYPE
5.1 Introduction
5.2 2D Cell Models
5.3 3D Cell Models
5.3.1Commercial 3D cell models
5.3.2In house 3D cell models
CHAPTER 6. GLOBAL IN VITRO LUNG MODEL MARKET – BY APPLICATION
6.1 Introduction
6.2 Applications of 2D Models
6.3 Applications of 3D Models
CHAPTER 7. GLOBAL IN VITRO LUNG MODEL MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL IN VITRO LUNG MODEL MARKET – COMPANY
PROFILES
8.1. Epithelix SAS.
8.2. MatTek Corporation
8.3. Lonza Group.
8.4. MIMETAS.
8.5. InSphero AG.
8.6. Emulate, Inc.
8.7. CN Bio Innovations.
8.8. Oncotheis.
8.9. TissUse GmbH.
8.10. American Type Culture Collection.
8.11. AlveoliX AG.
8.12. Well Doc Inc.
8.13. Twine Health, Inc.
8.14. Proteus Digital Health.
8.15. Zest Health, LLC.
CHAPTER 9. GLOBAL IN VITRO LUNG MODEL MARKET – COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.